Catalysts
DOCS Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
DOCS
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 67/100 and sentiment — before the next covered event.
Updated Sep 6, 2026 · Sentiment 37.84%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | — | $0.30 | $0.29 | -4.3% | $151.77M | $156.62M |
| May 13, 2026 | — | $0.28 | $0.26 | -7.1% | $144.03M | $145.37M |
| Feb 5, 2026 | — | $0.44 | $0.46 | +4.5% | $181.63M | $185.05M |
| Nov 6, 2025 | — | $0.38 | $0.45 | +18.8% | $157.9M | $168.53M |
| Aug 7, 2025 | — | $0.30 | $0.36 | +19.4% | $139.53M | $145.91M |
| May 15, 2025 | — | $0.27 | $0.38 | +39.9% | $133.73M | $138.29M |
| Feb 6, 2025 | — | $0.31 | $0.45 | +45.2% | $152.82M | $168.6M |
| Nov 7, 2024 | — | $0.25 | $0.30 | +20.0% | $127.13M | $136.83M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Related Links
DOCS Catalysts FAQ
What are the next catalysts for DOCS stock?
DOCS's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move DOCS stock?
Upcoming events that could move DOCS include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could DOCS's next earnings report affect the stock?
DOCS's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive DOCS stock higher?
DOCS could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt DOCS stock?
DOCS could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.